Brief: Amniotics To Expand Clinical Indications In Phase Ib Study Of Pulmostemtm

Amniotics AB (publ)

23/09/2022 10:55

Sept 23 (Reuters) - Amniotics AB (publ)  AMNI.ST :
    * AMNIOTICS PHASE IB STUDY OF PULMOSTEM™ TO INCLUDE BROADER PATIENT POPULATION
    * HAS RECEIVED APPROVAL FROM REGULATORY AUTHORITIES IN UK AND SWEDEN FOR A PROTOCOL
AMENDMENT
    * TO EXPAND CLINICAL INDICATIONS IN ITS PHASE IB STUDY OF PULMOSTEMTM TO ALSO INCLUDE
PATIENTS
WITH SEVERE LOWER RESPIRATORY TRACT INFECTIONS CAUSED BY OTHER VIRUSES THAN SARS-COV-2
(COVID-19)
    * STUDY IS CONDUCTED IN UK AND SWEDEN AND CLINICAL SITES ARE ACTIVATED AND READY TO START
RECRUITMENT

Source text for Eikon:  ID:nMFN9W2pSg 
Further company coverage:  AMNI.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))